Rick Winegar is the Lead Operating Partner at Blue Wolf Capital Partners LLC. The Blue Wolf Capital Funds are a family of private equity funds which focus on transformational investments in middle market companies.
Mr. Winegar has over 29 years of experience leading manufacturing and service company operations; guiding organizational transformation, performance turnarounds and IT systems implementations. Mr. Winegar leads Blue Wolf’s Operating Partner team and external resource network. Since joining Blue Wolf in 2012, he has served as the interim COO of Pearl Technologies, Inc., ModernMD Urgent Care and National Home Health Care. Mr. Winegar oversees operational due diligence and onboarding of portfolio companies, and is an active advisor and board observer for Twin Rivers Paper Company, Finch Paper Company LLC, ModernMD Urgent Care, Great Lakes Caring Home Health and Hospice, StateServ Holdings LLC and Extreme Plastics Plus. Mr. Winegar chairs Blue Wolf’s Safety, Health and Environmental Committee and sits on Blue Wolf’s ESG committee.
From 2010–2012, Mr. Winegar worked at Capgemini Consulting and led the startup of Capgemini’s North American manufacturing team. He served corporate and private equity clients in vaccine manufacturing, pulp and paper, Department of Defense, and capital equipment manufacturing. During this period, Mr. Winegar began his collaboration with Blue Wolf, serving as Lead Engagement Partner for Transformation Initiatives at Finch Paper Company LLC and Pearl Technologies, Inc.
Previously, Mr. Winegar served as a Principal at Tunnell Consulting, a leading operations and compliance consultancy serving Fortune 100 clients in life sciences and fine chemicals. Between 2001 and 2010, he led performance, quality, compliance, and cost transformation engagements across global networks for clients including Pfizer, Roche, and Watson Pharmaceuticals. Notably, from late 2005 to early 2007, Mr. Winegar led the critical expansion of Roche Pharmaceutical’s global Tamiflu supply chain, in response to the threat of an avian flu pandemic. As Roche’s external program manager, Mr. Winegar led a global team to successfully expand Tamiflu’s end to end supply chain capacity by 400% in 14 months; an effort that earned appreciation from national governments and the World Health Organization.
From 1990–2000, Mr. Winegar held a variety of roles of increasing responsibility at American Cyanamid, a $2 billion global agriculture and specialty chemicals producer. Early in his career at Cyanamid, Mr. Winegar worked in unionized shop floor environments, progressing rapidly through leadership roles in plant operations and contract manufacturing management to become Divisional Head of Quality, and finally Director of Latin American Manufacturing.
Mr. Winegar began his career at Chevron USA as a Production and Facilities Engineer overseeing the design, contracting, and installation of offshore oil and gas production facilities in the Gulf of Mexico.
Mr. Winegar received a B.S. in Mechanical Engineering from the University of Missouri-Columbia and an M.B.A. from Columbia University.